The Advanced Medical Solutions Sector is engaged in leading-edge medicines CDMO (Contract Development and Manufacturing Organization) business, including long-chain oligonucleotides, regenerative medicine and cell therapies, and small molecule drugs. We are also engaged in research and development of regenerative medicine and cell therapies. Through these solutions and products, we aim to meet a diverse range of medical and healthcare needs, contributing to healthier and more fulfilling lives.

For inquiries regarding Small Molecule APIs CDMO, Long-chain Oligonucleotides CDMO, and Regenerative Medicine and Cell Therapies business, please visit the following website.